DEFINITION
Population with access to essential drugs 2000. The data on access to essential drugs are based on
statistical estimates received from World
Health Organization (
WHO) country and regional offices and regional advisers and through the World Drug Situation Survey carried out in 1998-99. These estimates represent the best information available to the
WHO Department of Essential Drugs and Medicines Policy to date and are currently being validated by
WHO member states. The department assigns the estimates to four groupings: very low access (0-49%), low access (50-79%), medium access (80-94%) and good access (95-100%). These groupings, used here in presenting the data, are often employed by the
WHO in interpreting the data, as the actual estimates may suggest a higher level of accuracy than the data afford. b.
| Rank |
Countries
|
Amount
(top to bottom)
|
| #1 |
Kuwait: |
95% |
|
| #2 |
Denmark: |
95% |
|
| #3 |
Singapore: |
95% |
|
| #4 |
Cyprus: |
95% |
|
| #5 |
Sweden: |
95% |
|
| #6 |
United Arab Emirates: |
95% |
|
| #7 |
Jordan: |
95% |
|
| #8 |
Costa Rica: |
95% |
|
| #9 |
Germany: |
95% |
|
| #10 |
Greece: |
95% |
|
| #11 |
Estonia: |
95% |
|
| #12 |
Israel: |
95% |
|
| #13 |
Austria: |
95% |
|
| #14 |
Jamaica: |
95% |
|
| #15 |
Australia: |
95% |
|
| #16 |
Malta: |
95% |
|
| #17 |
Portugal: |
95% |
|
| #18 |
Italy: |
95% |
|
| #19 |
Canada: |
95% |
|
| #20 |
Hungary: |
95% |
|
| #21 |
Saudi Arabia: |
95% |
|
| #22 |
Libya: |
95% |
|
| #23 |
Fiji: |
95% |
|
| #24 |
Luxembourg: |
95% |
|
| #25 |
Ireland: |
95% |
|
| #26 |
Korea, South: |
95% |
|
| #27 |
United States: |
95% |
|
| #28 |
Grenada: |
95% |
|
| #29 |
New Zealand: |
95% |
|
| #30 |
Bahrain: |
95% |
|
| #31 |
Algeria: |
95% |
|
| #32 |
Norway: |
95% |
|
| #33 |
Slovakia: |
95% |
|
| #34 |
France: |
95% |
|
| #35 |
Mauritius: |
95% |
|
| #36 |
Turkey: |
95% |
|
| #37 |
Cuba: |
95% |
|
| #38 |
Iceland: |
95% |
|
| #39 |
United Kingdom: |
95% |
|
| #40 |
Slovenia: |
95% |
|
| #41 |
Barbados: |
95% |
|
| #42 |
Finland: |
95% |
|
| #43 |
Thailand: |
95% |
|
| #44 |
Croatia: |
95% |
|
| #45 |
Swaziland: |
95% |
|
| #46 |
Switzerland: |
95% |
|
| #47 |
Qatar: |
95% |
|
| #48 |
Spain: |
95% |
|
| #49 |
Belgium: |
95% |
|
| #50 |
Japan: |
95% |
|
| #51 |
Sri Lanka: |
95% |
|
| #52 |
Netherlands: |
95% |
|
| #53 |
Suriname: |
95% |
|
| #54 |
Syria: |
80% |
|
| #55 |
Cape Verde: |
80% |
|
| #56 |
Latvia: |
80% |
|
| #57 |
Egypt: |
80% |
|
| #58 |
Poland: |
80% |
|
| #59 |
Vietnam: |
80% |
|
| #60 |
Comoros: |
80% |
|
| #61 |
Panama: |
80% |
|
| #62 |
Dominica: |
80% |
|
| #63 |
Lebanon: |
80% |
|
| #64 |
Cote d'Ivoire: |
80% |
|
| #65 |
El Salvador: |
80% |
|
| #66 |
South Africa: |
80% |
|
| #67 |
Djibouti: |
80% |
|
| #68 |
Chile: |
80% |
|
| #69 |
Indonesia: |
80% |
|
| #70 |
Romania: |
80% |
|
| #71 |
Iran: |
80% |
|
| #72 |
Colombia: |
80% |
|
| #73 |
Guinea: |
80% |
|
| #74 |
Bulgaria: |
80% |
|
| #75 |
Botswana: |
80% |
|
| #76 |
Lithuania: |
80% |
|
| #77 |
Mexico: |
80% |
|
| #78 |
Bahamas, The: |
80% |
|
| #79 |
Czech Republic: |
80% |
|
| #80 |
Gambia, The: |
80% |
|
| #81 |
China: |
80% |
|
| #82 |
Belize: |
80% |
|
| #83 |
Namibia: |
80% |
|
| #84 |
Bhutan: |
80% |
|
| #85 |
Papua New Guinea: |
80% |
|
| #86 |
Seychelles: |
80% |
|
| #87 |
Lesotho: |
80% |
|
| #88 |
Venezuela: |
80% |
|
| #89 |
Solomon Islands: |
80% |
|
| #90 |
Oman: |
80% |
|
| #91 |
Mali: |
50% |
|
| #92 |
Bolivia: |
50% |
|
| #93 |
Malaysia: |
50% |
|
| #94 |
Antigua and Barbuda: |
50% |
|
| #95 |
Belarus: |
50% |
|
| #96 |
Senegal: |
50% |
|
| #97 |
Saint Lucia: |
50% |
|
| #98 |
Philippines: |
50% |
|
| #99 |
Morocco: |
50% |
|
| #100 |
Zimbabwe: |
50% |
|
| #101 |
Maldives: |
50% |
|
| #102 |
Saint Kitts and Nevis: |
50% |
|
| #103 |
Central African Republic: |
50% |
|
| #104 |
Azerbaijan: |
50% |
|
| #105 |
Laos: |
50% |
|
| #106 |
Albania: |
50% |
|
| #107 |
Turkmenistan: |
50% |
|
| #108 |
Uganda: |
50% |
|
| #109 |
Zambia: |
50% |
|
| #110 |
Ethiopia: |
50% |
|
| #111 |
Niger: |
50% |
|
| #112 |
Benin: |
50% |
|
| #113 |
Guatemala: |
50% |
|
| #114 |
Mongolia: |
50% |
|
| #115 |
Uruguay: |
50% |
|
| #116 |
Russia: |
50% |
|
| #117 |
Burkina Faso: |
50% |
|
| #118 |
Mozambique: |
50% |
|
| #119 |
Kyrgyzstan: |
50% |
|
| #120 |
Burma: |
50% |
|
| #121 |
Kazakhstan: |
50% |
|
| #122 |
Tunisia: |
50% |
|
| #123 |
Madagascar: |
50% |
|
| #124 |
Uzbekistan: |
50% |
|
| #125 |
Trinidad and Tobago: |
50% |
|
| #126 |
Togo: |
50% |
|
| #127 |
Congo, Democratic Republic of the: |
50% |
|
| #128 |
Dominican Republic: |
50% |
|
| #129 |
Mauritania: |
50% |
|
| #130 |
Peru: |
50% |
|
| #131 |
Pakistan: |
50% |
|
| #132 |
Eritrea: |
50% |
|
| #133 |
Cameroon: |
50% |
|
| #134 |
Ukraine: |
50% |
|
| #135 |
Yemen: |
50% |
|
| #136 |
Argentina: |
50% |
|
| #137 |
Bangladesh: |
50% |
|
| #138 |
Haiti: |
0% |
|
| #139 |
Nepal: |
0% |
|
| #140 |
Nicaragua: |
0% |
|
| #141 |
Ghana: |
0% |
|
| #142 |
Rwanda: |
0% |
|
| #143 |
Georgia: |
0% |
|
| #144 |
Brazil: |
0% |
|
| #145 |
Sierra Leone: |
0% |
|
| #146 |
Kenya: |
0% |
|
| #147 |
Sudan: |
0% |
|
| #148 |
Angola: |
0% |
|
| #149 |
Guyana: |
0% |
|
| #150 |
Tajikistan: |
0% |
|
| #151 |
Burundi: |
0% |
|
| #152 |
Gabon: |
0% |
|
| #153 |
Paraguay: |
0% |
|
| #154 |
Equatorial Guinea: |
0% |
|
| #155 |
Armenia: |
0% |
|
| #156 |
Malawi: |
0% |
|
| #157 |
Chad: |
0% |
|
| #158 |
Cambodia: |
0% |
|
| #159 |
Ecuador: |
0% |
|
| #160 |
Honduras: |
0% |
|
| #161 |
Nigeria: |
0% |
|
| #162 |
India: |
0% |
|
| #163 |
Guinea-Bissau: |
0% |
|
| |
Weighted average: |
63.5% |
|
DEFINITION: Population with access to essential drugs 2000. The data on access to essential drugs are based on
statistical estimates received from World
Health Organization (
WHO) country and regional offices and regional advisers and through the World Drug Situation Survey carried out in 1998-99. These estimates represent the best information available to the
WHO Department of Essential Drugs and Medicines Policy to date and are currently being validated by
WHO member states. The department assigns the estimates to four groupings: very low access (0-49%), low access (50-79%), medium access (80-94%) and good access (95-100%). These groupings, used here in presenting the data, are often employed by the
WHO in interpreting the data, as the actual estimates may suggest a higher level of accuracy than the data afford. b.